Cargando…
TP53 isoform junction reads based analysis in malignant and normal contexts
TP53 is one of the most frequently altered genes in cancer; it can be inactivated by a number of different mechanisms. NM_000546.6 (ENST00000269305.9) is by far the predominant TP53 isoform, however a few other alternative isoforms have been described to be expressed at much lower levels. To better...
Autores principales: | Vural, Suleyman, Chang, Lun-Ching, Yee, Laura M., Sonkin, Dmitriy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390641/ https://www.ncbi.nlm.nih.gov/pubmed/34446762 http://dx.doi.org/10.1038/s41598-021-96700-1 |
Ejemplares similares
-
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015) -
Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013) -
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
por: Anbalagan, Selvakumar, et al.
Publicado: (2021) -
p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2023) -
Genomic landscape of TP53-mutated myeloid malignancies
por: Abel, Haley J., et al.
Publicado: (2023)